The vision of the project is to increase feasibility of antibiotic drug development. This will be done through providing a strategy leading to a reduced number of patients needed to support clinical efficacy. The strategy consists of a model-based framework for the analysis and design of clinical trials that evaluates efficacy for the antibiotic treatment of patients infected with bacteria resistant to current drugs.